Shutterstock
Q&A: Investing in Life Science
Following the DVPs first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing. Read more
15 Apr 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
Chris Sutherland
Scotland’s Life Sciences Sector Poised for Growth
Speaking at an event in Edinburgh, Chris Dougray, Head of Development at CBRE Scotland, and Chris Williams, CBRE’s Head of Life Sciences, joined forces to examine the burgeoning sector’s place in Scotland. Read more
14 Mar 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
UK biotech company responds to approval changes and R&D tax relief
Last Thursday, chancellor Jeremy Hunt announced new measures for smoother medicine approvals in the UK, increased support for R&D, and a simplified tax system for SMEs. UK biotech company, Nevrargenics shared its position on the 2023 Budget. Read more
23 Mar 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Vitalii Stock Shutterstock
Why invest in pharma in times of a recession?
Léone Atayi, CEO of Hybrigenics and Stemcis, discusses the importance of investing in the pharmaceutical industry amid a recession. Read more
21 Feb 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Smart Financing and CROs: investing in digitalisation for drug development
Sally-Anne Whybrow, healthcare business development manager, Siemens Financial Services, UK examines how smart financing can help CROs invest in financially-sustainable technology. Read more
5 Oct 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Q&A with Lonza: Support for biotech startups
Following on from their recent partnership with Israel Biotech Fund (IBF), EPM caught up with Lonza's Pnina Weitz on the importance of early-stage support for emerging companies, and how robust strategies early on can pave a way to commercialisation. Read more
29 Jun 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Pixel Alchemy/Adobe Stock
Starget Pharma secures $5.1 million investment for targeted cancer therapy
ARC Innovation announced the successful $5.1 million funding round of Starget Pharma, a startup specialising in precise cancer diagnosis and targeted radiotherapy. Read more
5 Nov 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Katy Balls/Getty Images
R&D funding and capital gains: What the budget means for life sciences
This week’s budget saw several major announcements for the UK life sciences sector. Yogan Patel, head of life sciences for MHA, the UK member firm of the global Baker Tilly network, explores what’s been announced and what it means for the industry. Read more
1 Nov 2024
Pharma Manufacturing News + Pharma Finance and Investment News
IM Imagery/Adobe Stock
Recipharm invests in sterile development capabilities
Recipharm is expanding its pharmaceutical development capabilities through targeted investments and the integration of advanced technologies. Read more
4 Oct 2024
Pharma Manufacturing News + Pharma Finance and Investment News
sumroeng chinnapan/Shutterstock
Advancing the respiratory treatment market with low-emission propellants
Editor Rebekah Jordan spoke to Honeywell to explore its long-term supply agreement with DevPro Biopharma to develop a respiratory inhaler that enhances the well-being of patients. Read more
22 Nov 2024
IntelliPixelForge/Adobe Stock
Where AI meets genetics: Accelerating small molecule drug development
Editor Rebekah Jordan spoke to Kevin Kreutter, Ph.D., senior vice president, Drug Discovery, Empress Therapeutics about how the company is using AI to analyse genetic data, to accelerate and refine small molecule drug discovery. Read more
21 Nov 2024
Maarten Zeehandelaar/Shutterstock
Signposting the route to sustainable devices with life-cycle assessment
Alex Fong, insights and sustainability lead, Owen Mumford, addresses the environmental impact of single-use drug delivery devices and emphasises the role of life-cycle assessment (LCA) in sustainable design. Read more
18 Nov 2024
Resilience
Futureproofing medicines manufacturing with virtual solutions
Editor Rebekah Jordan speaks to Ivan Wall, a professor at the University of Birmingham and co-director of the Resilience project, to learn about the advancements the initiative is making in UK medicines manufacturing. Read more
15 Nov 2024
Broughton
Three essential tips for stability partner selection
Broughton highlights the top three tips in choosing a stability partner and explains how its extensive expertise positions it as a leader in stability testing. Read more
12 Nov 2024
asadykov/Adobe Stock
Trends shaping collaborations in drug development and manufacturing
Given the success of nasal drug-delivery products relies on balancing formulation and device selection, Eric Kaneps at Renaissance Lakewood, LLC explains the importance of partnerships and collaborations drug development and manufacturing. Read more
8 Nov 2024
Sponsored Content
TierneyMJ / Shutterstock.com
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
